Patent details

Basic Information

Publication number:

EP2553096

PCT Application Number:

JP2011001909

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP117622654

PCT Publication Number:

WO2011122022

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ECT2 PEPTIDES AND VACCINES INCLUDING THE SAME

French Title of Invention:

PEPTIDES D'ECT2 ET VACCINS LES COMPRENANT

German Title of Invention:

ECT2-PEPTIDE UND DIESE ENTHALTENDE IMPFSTOFFE

SPC Number:

Dates

Filing date:

30/03/2011

Grant date:

22/11/2017

EP Publication Date:

06/02/2013

PCT Publication Date:

06/10/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

22/11/2017

EP B1 Publication Date:

22/11/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

30/03/2018

Expiration date:

30/03/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/11/2017

 

 

Name:

Oncotherapy Science, Inc.

Address:

2-1, Sakado 3-chome Takatsu-ku, Kawasaki-shi Kanagawa 213-0012, Japan (JP)

Inventor

1

Name:

WATANABE, Tomohisa

Address:

Japan (JP)

2

Name:

TSUNODA, Takuya

Address:

Japan (JP)

3

Name:

YOSHIMURA, Sachiko

Address:

Japan (JP)

4

Name:

OHSAWA, Ryuji

Address:

Japan (JP)

5

Name:

NAKAMURA, Yusuke

Address:

Japan (JP)

Priority

Priority Number:

320577 P

Priority Date:

02/04/2010

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/00; C07K 7/06; C12N 15/09;

Publication

European Patent Bulletin

Issue number:

201747

Publication date:

22/11/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
31/07/2018	Outgoing Correspondence	1